Surprisingly, we found that in contrast to the effects of HDAC6i, the pan-HDACi panobinostat increased the expression of genes that had been induced by RT, indicating that HDAC6 inhibition may have a higher specificity and better efficacy against BC. This evidence concerns the gene HDAC6 and breast cancer.